News
$BioXcel Therapeutics(BTAI.US$ Reuters · just BioXcel Therapeutics Announces Positive Topline Results From Post-Marketing Requirement Study Evaluating Prn Treatment of Igalmi™ (Dexmedetomidine) Sublingual Film for Agitation Associated With Bipolar Disorders or Schizophrenia
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Trytosaveabit OP : BioXcel Therapeutics Inc: Study Achieved Its Objective